Effection of RANKL on transplantation of bone marrow mesenchymal stem cells after cerebral ischemia in adult rats

赵宗茂,孙国柱,张庆俊,刘海英,郭丽,韩忠朝

DOI: https://doi.org/10.3321/j.issn:1001-9030.2008.10.026

2008-01-01

Abstract:Objective To observe the effect of receptor activator of NF Kappa B ligand (RANKL) on neurological functional recovery and neural differentiation after transplantation of bone marrow mesenehymal stem cells (hBMSCs) to adult rats with middle cerebral artery occlusion ( MCAO ). Methods Sixty adult SD rats were subjected to left MCAO,then BrdU-labeled hBMSCs and RANKL were injected to the marginal zone of cerebral ischemla 24 h after MCAO. Functional outcome measurements were performed at 1,7,14,21 and 28 days after transplantation. Brain sections were examined using immunohistochemical and immunofluorescence staining methods to detect that ff BrdU-labeled adult human bmarrow mesenchymal stem cells expressed the astrocytie marker-glial fibriliary acidic protein (GFAP) and the neuron marker-neuron-specific enolase(NSE). Results A better neurological functional outcome was found in hBMSCs + RANKL group than in hMSCs group at day 7 to 21. More BrdU-NSE (4, 39% ) and BrdU-GFAP (9.06%) immuuoreactive hBMSCs were detected in rats that underwent hBMSCs and RANKL transplantation than hBMSCs injection only (2.93% and 8.03%, respectively). Conclusion Transplantation of hBMSCs in combination with RANKL improves neurological outcome after cerebral isehemia, and facilitates hBMSCs differentiation into neural cells.